99 related articles for article (PubMed ID: 2483383)
1. Production and characterization of monoclonal antibodies to fibrinogen.
Cox D; O'Kennedy R; Carroll K
Biochem Soc Trans; 1989 Dec; 17(6):1057-8. PubMed ID: 2483383
[No Abstract] [Full Text] [Related]
2. Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products.
Amiral J; Grosley M; Mimilla F; Plassart V; Chambrette B
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):447-52. PubMed ID: 1723302
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen-fibrin: preparation and use of monoclonal antibodies as diagnostics.
Kudryk BJ; Bini A; Rosebrough SF; Schaible TF
Biotechnology; 1991; 19():281-313. PubMed ID: 1723912
[No Abstract] [Full Text] [Related]
4. Markers of fibrinogen derivatives used in clinical investigation.
Soria J; Soria C; Mirshahi M; Samama MM
Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296
[No Abstract] [Full Text] [Related]
5. Some studies with a monoclonal antibody directed against human fibrinogen.
Francis SE; Joshua DE; Exner T; Kronenberg H
Am J Hematol; 1985 Feb; 18(2):111-9. PubMed ID: 2578730
[TBL] [Abstract][Full Text] [Related]
6. Production and characterization of a monoclonal antibody reactive with a specific neoantigenic determinant (comprising B beta 54-118) in degradation products of fibrin and of fibrinogen.
Koppert PW; Koopman J; Haverkate F; Nieuwenhuizen W
Blood; 1986 Aug; 68(2):437-41. PubMed ID: 3730608
[TBL] [Abstract][Full Text] [Related]
7. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
8. Evolutionary stability of fibrinogen epitopes implicated in fibrin polymerization and in fibrinolysis.
Mirshahi M; Mirshahi SS; Soria C; Perrot JY; Guidalia M; Boucheix C; Soria J
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):427-31. PubMed ID: 2133218
[TBL] [Abstract][Full Text] [Related]
9. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
Dyr JE; Cajthamlová H; Suttnar J
Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
[TBL] [Abstract][Full Text] [Related]
10. [A group of monoclonal antibodies against human fibrinogen and its fragments].
Wu XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Aug; 10(4):288-90. PubMed ID: 2976318
[No Abstract] [Full Text] [Related]
11. Proceedings: Gamma'-dimer antibody and its specificity against fibrinogen, FR-a and carboxymethylated chains from fibrinogen and cross-linked fibrin.
Clausen NT; Gormsen J
Thromb Diath Haemorrh; 1975 Sep; 34(1):326. PubMed ID: 1188740
[No Abstract] [Full Text] [Related]
12. Isolation and characterization of a monoclonal antibody specific for fibrinogen and fibrin of human origin.
Sola B; Avner PR; Zilber MT; Connan F; Lévy D
Thromb Res; 1983 Mar; 29(6):643-53. PubMed ID: 6857603
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies of predetermined specificity for fibrin: a rational approach to monoclonal antibody production.
Hui KY; Haber E; Matsueda GR
Hybridoma; 1986; 5(3):215-22. PubMed ID: 2429911
[TBL] [Abstract][Full Text] [Related]
14. Two monoclonal antibodies to D-dimer-specific inhibitors of fibrin polymerization.
Lugovskoy EV; Gritsenko PG; Kolesnikova IN; Zolotarova EN; Chernishov VI; Nieuwenhuizen W; Komisarenko SV
Thromb Res; 2004; 113(3-4):251-9. PubMed ID: 15140590
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). I. Characterization and preliminary evaluation in plasma.
Gaffney PJ; Creighton LJ; Perry MJ; Callus M; Thorpe R; Spitz M
Br J Haematol; 1988 Jan; 68(1):83-90. PubMed ID: 3345297
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the chains of human fibrinogen isolated by perfusion chromatography using fibrin specific monoclonal antibodies.
Raut S; Corran PH; Gaffney PJ
Thromb Res; 1995 Aug; 79(4):405-13. PubMed ID: 7482444
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to fibrinogen-fibrin degradation products which contain D-domain.
Matsumoto T; Nishijima Y; Teramura Y; Fujino K; Hibino M; Hirata M
Thromb Res; 1985 May; 38(3):297-302. PubMed ID: 2410999
[No Abstract] [Full Text] [Related]
19. Radioimmunoassay of fibrinogen-fibrin degradation products: assay for fragment E-related neoantigen-methodological aspects.
Chen JP; Schulof RS
Thromb Res; 1979; 16(5-6):601-15. PubMed ID: 93312
[No Abstract] [Full Text] [Related]
20. Surface markers of fibrinogen and its physiologic derivatives revealed by antibody probes.
Plow EF; Edgington TS
Semin Thromb Hemost; 1982 Jan; 8(1):36-56. PubMed ID: 6173923
[No Abstract] [Full Text] [Related]
[Next] [New Search]
